Myonexus Therapeutics procures $2.5 mln seed

New Albany, Ohio-based Myonexus Therapeutics Inc, a developer of transformative gene therapies for limb-girdle muscular dystrophies, has closed $2.5 million in seed financing. The investors included CincyTech LLC, Rev1 Ventures, The Jain Foundation and GFB ONLUS.

ManagersNorth AmericaUSHealthcareBriefs